RIFAXIMIN

RIFAXIMIN was reported 21335 times

RIFAXIMIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PORTAL SHUNT PROCEDURE 26 0.3714
1 GASTROINTESTINAL BACTERIAL OVERGROWTH 113 0.1883
2 AMMONIA INCREASED 862 0.1688
3 AMMONIA ABNORMAL 60 0.1489
4 GASTROINTESTINAL MICROORGANISM OVERGROWTH 50 0.1420
5 ANTI-TRANSGLUTAMINASE ANTIBODY INCREASED 7 0.1207
6 HEPATIC HYDROTHORAX 9 0.1139
7 PORTAL SHUNT 9 0.1111
8 PARACENTESIS 57 0.0927
9 AMMONIA DECREASED 7 0.0897
10 HEPATIC ENCEPHALOPATHY 836 0.0895
11 CIRRHOSIS ALCOHOLIC 40 0.0873
12 OVERGROWTH BACTERIAL 20 0.0743
13 INABILITY TO AFFORD MEDICATION 707 0.0711
14 PORTAL HYPERTENSIVE GASTROPATHY 35 0.0621
15 SPIDER NAEVUS 10 0.0541
16 INSURANCE ISSUE 729 0.0476
17 LIVER TRANSPLANT 171 0.0470
18 SICCA SYNDROME 9 0.0466
19 ABDOMINAL CAVITY DRAINAGE 18 0.0427
20 HEPATIC CIRRHOSIS 707 0.0376
21 VARICES OESOPHAGEAL 106 0.0350
22 NON-ALCOHOLIC STEATOHEPATITIS 36 0.0347
23 COMPLICATIONS OF TRANSPLANTED LIVER 12 0.0333
24 SPONTANEOUS BACTERIAL PERITONITIS 8 0.0328
25 LIVER OPERATION 10 0.0325
26 GASTRIC VARICES 15 0.0318
27 METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS 8 0.0315
28 HEPATORENAL SYNDROME 50 0.0296
29 UREAPLASMA INFECTION 12 0.0294
30 HEPATIC INFARCTION 11 0.0292
31 GASTRIC ANTRAL VASCULAR ECTASIA 15 0.0284
32 HEPATITIS ALCOHOLIC 8 0.0245
33 HOSPICE CARE 239 0.0242
34 INTRA-ABDOMINAL FLUID COLLECTION 42 0.0234
35 ASTERIXIS 23 0.0216
36 OESOPHAGEAL VARICES HAEMORRHAGE 46 0.0212
37 ALCOHOLIC LIVER DISEASE 7 0.0206
38 PORTAL HYPERTENSION 62 0.0201
39 HYPERAMMONAEMIC ENCEPHALOPATHY 33 0.0190
40 SYMPTOM RECURRENCE 109 0.0182
41 TRANSPLANT EVALUATION 9 0.0177
42 MEGACOLON 27 0.0172
43 PRIMARY BILIARY CHOLANGITIS 8 0.0170
44 ENTEROCOCCUS TEST POSITIVE 11 0.0170
45 SHORT-BOWEL SYNDROME 11 0.0169
46 HEPATIC FAILURE 507 0.0168
47 THERAPY INTERRUPTED 1176 0.0164
48 DRUG SPECIFIC ANTIBODY 22 0.0161
49 POUCHITIS 13 0.0151
50 DISEASE COMPLICATION 68 0.0148
51 BLEEDING VARICOSE VEIN 8 0.0148
52 PRODUCT DIFFICULT TO SWALLOW 14 0.0138
53 OESOPHAGEAL HAEMORRHAGE 17 0.0128
54 HOSPITALISATION 1954 0.0127
55 ALPHA 1 FOETOPROTEIN INCREASED 9 0.0126
56 ASCITES 370 0.0126
57 COMA HEPATIC 9 0.0121
58 LIVER DISORDER 520 0.0117
59 PSEUDOMEMBRANOUS COLITIS 26 0.0116
60 PRODUCT SUPPLY ISSUE 83 0.0116
61 GASTROINTESTINAL BACTERIAL INFECTION 13 0.0114
62 TRANSPLANT 25 0.0105
63 CLOSTRIDIUM TEST POSITIVE 23 0.0104
64 HEPATIC INFECTION 13 0.0102
65 PRODUCT DISTRIBUTION ISSUE 91 0.0098
66 HYPERAMMONAEMIA 47 0.0094
67 HEPATIC HAEMORRHAGE 8 0.0093
68 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 12 0.0091
69 HEPATIC MASS 17 0.0088
70 WAIST CIRCUMFERENCE INCREASED 9 0.0087
71 PORTAL VEIN THROMBOSIS 27 0.0083
72 HYPOPROTEINAEMIA 15 0.0079
73 HYPERVOLAEMIA 39 0.0079
74 PRODUCT SIZE ISSUE 42 0.0078
75 FUNCTIONAL GASTROINTESTINAL DISORDER 27 0.0078
76 IRRITABLE BOWEL SYNDROME 167 0.0078
77 PNEUMATOSIS INTESTINALIS 22 0.0077
78 ESSENTIAL HYPERTENSION 14 0.0076
79 HEPATIC CANCER 177 0.0074
80 SHOULDER FRACTURE 12 0.0073
81 RECTAL TENESMUS 9 0.0072
82 ENCEPHALOPATHY 176 0.0072
83 THERAPY CESSATION 365 0.0071
84 HEPATIC NEOPLASM 23 0.0070
85 ENTHESOPATHY 11 0.0070
86 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 23 0.0070
87 HEPATOCELLULAR CARCINOMA 52 0.0068
88 VASCULAR DEVICE INFECTION 31 0.0068
89 BILIARY DILATATION 10 0.0068
90 TREATMENT NONCOMPLIANCE 366 0.0067
91 ABDOMINAL INFECTION 17 0.0066
92 HYPERPARATHYROIDISM SECONDARY 16 0.0064
93 LIP HAEMORRHAGE 8 0.0063
94 GASTRIC POLYPS 14 0.0062
95 PRODUCT USE COMPLAINT 96 0.0061
96 REHABILITATION THERAPY 23 0.0059
97 HEPATIC LESION 25 0.0058
98 SMALL INTESTINAL OBSTRUCTION 71 0.0058
99 PATIENT DISSATISFACTION WITH TREATMENT 11 0.0057
100 INTENSIVE CARE 8 0.0056
101 INTERNAL HAEMORRHAGE 62 0.0054
102 HAEMORRHAGIC DIATHESIS 19 0.0053
103 MENTAL STATUS CHANGES 144 0.0052
104 ANAL INCONTINENCE 46 0.0051
105 INFUSION SITE BRUISING 11 0.0051
106 BILIARY TRACT DISORDER 7 0.0051
107 METABOLIC ENCEPHALOPATHY 15 0.0050
108 NEPHROGENIC ANAEMIA 23 0.0050
109 DEATH 4264 0.0049
110 INCONTINENCE 52 0.0049
111 SYSTEMIC INFECTION 8 0.0048
112 SKIN NECROSIS 25 0.0048
113 CYTOMEGALOVIRUS INFECTION REACTIVATION 21 0.0047
114 TERMINAL STATE 31 0.0046
115 HYPOALBUMINAEMIA 36 0.0046
116 FREQUENT BOWEL MOVEMENTS 123 0.0045
117 CONFUSIONAL STATE 733 0.0045
118 DEVICE RELATED SEPSIS 9 0.0045
119 ORGAN FAILURE 18 0.0045
120 ABDOMINAL DISTENSION 459 0.0044
121 PNEUMONIA KLEBSIELLA 8 0.0043
122 UMBILICAL HERNIA 20 0.0043
123 ABNORMAL FAECES 35 0.0043
124 PRODUCT AVAILABILITY ISSUE 97 0.0043
125 BLOOD SODIUM DECREASED 80 0.0042
126 PRODUCT PRESCRIBING ERROR 101 0.0042
127 HEPATITIS C 50 0.0041
128 APLASIA 8 0.0041
129 CLOSTRIDIUM DIFFICILE INFECTION 88 0.0040
130 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114 0.0040
131 INFREQUENT BOWEL MOVEMENTS 10 0.0040
132 TOXIC ENCEPHALOPATHY 20 0.0039
133 PRODUCT PRESCRIBING ISSUE 86 0.0039
134 DIALYSIS 56 0.0039
135 SPLENOMEGALY 46 0.0039
136 CHOLANGITIS SCLEROSING 8 0.0039
137 QUALITY OF LIFE DECREASED 52 0.0039
138 NERVE INJURY 43 0.0039
139 NEUROLOGICAL SYMPTOM 22 0.0038
140 IRON DEFICIENCY ANAEMIA 35 0.0038
141 IRON DEFICIENCY 17 0.0038
142 CLOSTRIDIUM DIFFICILE COLITIS 40 0.0038
143 DEFAECATION URGENCY 26 0.0037
144 PERITONITIS BACTERIAL 37 0.0037
145 MALNUTRITION 41 0.0037
146 DIVERTICULUM INTESTINAL 16 0.0037
147 PARESIS 8 0.0036
148 HYPERBILIRUBINAEMIA 37 0.0036
149 END STAGE RENAL DISEASE 65 0.0036
150 CHRONIC GASTRITIS 8 0.0035
151 DIARRHOEA HAEMORRHAGIC 33 0.0035
152 ILL-DEFINED DISORDER 214 0.0035
153 ABDOMINAL ADHESIONS 11 0.0035
154 GRAFT VERSUS HOST DISEASE 25 0.0035
155 OCULAR ICTERUS 15 0.0035
156 FLUID RETENTION 176 0.0035
157 GASTROINTESTINAL INFECTION 31 0.0035
158 LOCALISED OEDEMA 16 0.0035
159 HAEMATEMESIS 86 0.0034
160 GASTROINTESTINAL MOTILITY DISORDER 18 0.0034
161 MEDICATION RESIDUE PRESENT 16 0.0033
162 FLATULENCE 190 0.0033
163 SUSPECTED OFF LABEL USE 15 0.0033
164 FLUID OVERLOAD 48 0.0033
165 HEPATIC PAIN 14 0.0033
166 DYSCHEZIA 10 0.0033
167 HAEMATOLOGICAL INFECTION 8 0.0033
168 DIABETIC FOOT 10 0.0033
169 BOWEL MOVEMENT IRREGULARITY 25 0.0033
170 BLOOD BILIRUBIN INCREASED 88 0.0033
171 RENAL FAILURE 427 0.0032
172 UPPER LIMB FRACTURE 64 0.0032
173 PERIPHERAL VENOUS DISEASE 13 0.0032
174 URINARY TRACT INFECTION BACTERIAL 8 0.0032
175 INTENTIONAL UNDERDOSE 23 0.0031
176 INCOHERENT 20 0.0031
177 HERNIA REPAIR 8 0.0031
178 CROHN'S DISEASE 21 0.0031
179 PRODUCT USE ISSUE 574 0.0031
180 FAECES DISCOLOURED 66 0.0030
181 KLEBSIELLA INFECTION 15 0.0030
182 BLOOD SODIUM INCREASED 8 0.0030
183 BRADYPNOEA 8 0.0030
184 COLITIS ISCHAEMIC 20 0.0030
185 DISEASE RECURRENCE 141 0.0030
186 TRANSFUSION 31 0.0030
187 CLONUS 8 0.0029
188 HAEMORRHOIDS 57 0.0029
189 CANDIDA INFECTION 49 0.0029
190 FAILURE TO THRIVE 15 0.0029
191 LARGE INTESTINE POLYP 20 0.0029
192 FOREIGN BODY IN THROAT 9 0.0029
193 PANCREATIC DISORDER 14 0.0028
194 BILE DUCT STONE 9 0.0028
195 FAECES HARD 11 0.0028
196 ABDOMINAL TENDERNESS 14 0.0028
197 ULCER HAEMORRHAGE 19 0.0028
198 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 81 0.0028
199 INTENTIONAL PRODUCT USE ISSUE 242 0.0028
200 HIP FRACTURE 88 0.0027
201 PSYCHIATRIC SYMPTOM 20 0.0027
202 HIATUS HERNIA 35 0.0027
203 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 11 0.0027
204 BLOOD MAGNESIUM DECREASED 23 0.0027
205 WOUND DEHISCENCE 9 0.0027
206 POLYARTHRITIS 14 0.0027
207 COAGULOPATHY 44 0.0026
208 SPRUE-LIKE ENTEROPATHY 13 0.0026
209 ACUTE HEPATIC FAILURE 36 0.0026
210 ABDOMINAL HERNIA 12 0.0026
211 BLOOD POTASSIUM DECREASED 79 0.0026
212 GASTROINTESTINAL SOUNDS ABNORMAL 13 0.0026
213 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 10 0.0026
214 BACTERAEMIA 31 0.0026
215 DISORIENTATION 103 0.0026
216 POLYP 17 0.0026
217 ELECTROLYTE IMBALANCE 30 0.0026
218 ABDOMINAL RIGIDITY 7 0.0026
219 RENAL DISORDER 119 0.0026
220 ESCHERICHIA INFECTION 21 0.0026
221 INTESTINAL ISCHAEMIA 14 0.0025
222 ATRIOVENTRICULAR BLOCK COMPLETE 17 0.0025
223 RECTAL HAEMORRHAGE 109 0.0025
224 JAUNDICE 68 0.0025
225 DYSPHEMIA 11 0.0025
226 RENAL TRANSPLANT 9 0.0025
227 ENTEROCOCCAL INFECTION 12 0.0025
228 PLATELET COUNT ABNORMAL 15 0.0025
229 SCLERODERMA 9 0.0025
230 BLOOD POTASSIUM INCREASED 40 0.0025
231 BACTERIAL SEPSIS 8 0.0025
232 UNRESPONSIVE TO STIMULI 63 0.0024
233 GASTRIC HAEMORRHAGE 28 0.0024
234 VENOOCCLUSIVE LIVER DISEASE 12 0.0024
235 NEAR DEATH EXPERIENCE 8 0.0024
236 BILIARY COLIC 7 0.0024
237 BRAIN FOG 37 0.0024
238 CLAVICLE FRACTURE 9 0.0023
239 HEPATOMEGALY 23 0.0023
240 COLITIS MICROSCOPIC 11 0.0023
241 MYOPATHY 20 0.0023
242 ACUTE KIDNEY INJURY 353 0.0023
243 PATHOGEN RESISTANCE 21 0.0023
244 IMPAIRED QUALITY OF LIFE 33 0.0023
245 SKIN ODOUR ABNORMAL 9 0.0023
246 CATATONIA 12 0.0023
247 HYPOGAMMAGLOBULINAEMIA 15 0.0023
248 DISSEMINATED INTRAVASCULAR COAGULATION 32 0.0023
249 BLOOD ALBUMIN DECREASED 18 0.0023
250 BRAIN DEATH 7 0.0023
251 CEREBRAL ATROPHY 9 0.0023
252 SEPTIC SHOCK 98 0.0022
253 FOOD POISONING 12 0.0022
254 PRODUCT USE IN UNAPPROVED INDICATION 555 0.0022
255 CHRONIC KIDNEY DISEASE 170 0.0022
256 VASCULITIS 26 0.0022
257 SEPSIS 248 0.0022
258 MUCOUS STOOLS 11 0.0022
259 CONDITION AGGRAVATED 669 0.0022
260 ASPIRATION 24 0.0022
261 FOOD INTOLERANCE 8 0.0022
262 GASTROINTESTINAL PAIN 24 0.0022
263 STREPTOCOCCAL INFECTION 12 0.0022
264 RENAL CYST 17 0.0021
265 ABDOMINAL PAIN 497 0.0021
266 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 117 0.0021
267 VARICOSE VEIN 11 0.0021
268 HERNIA 41 0.0021
269 DEMENTIA 59 0.0021
270 CHOLANGITIS 13 0.0021
271 GASTRIC INFECTION 8 0.0021
272 HAEMATOCHEZIA 115 0.0021
273 FAECAL INCONTINENCE 10 0.0021
274 HUMERUS FRACTURE 10 0.0021
275 FEEDING DISORDER 42 0.0021
276 HYPONATRAEMIA 116 0.0021
277 TONGUE DISCOLOURATION 9 0.0021
278 PELVIC FRACTURE 16 0.0021
279 IMPAIRED GASTRIC EMPTYING 28 0.0021
280 COMPRESSION FRACTURE 11 0.0021
281 HEPATIC STEATOSIS 38 0.0020
282 VULVOVAGINAL MYCOTIC INFECTION 8 0.0020
283 URINARY TRACT INFECTION 346 0.0020
284 GENERALISED OEDEMA 25 0.0020
285 HEPATITIS ACUTE 13 0.0020
286 DRUG SPECIFIC ANTIBODY PRESENT 13 0.0020
287 FOREIGN BODY 8 0.0020
288 RIGHT VENTRICULAR FAILURE 14 0.0020
289 COMA 95 0.0020
290 RIB FRACTURE 41 0.0020
291 SEROTONIN SYNDROME 38 0.0020
292 OEDEMA 107 0.0020
293 DIARRHOEA 1258 0.0019
294 VITAMIN D DEFICIENCY 19 0.0019
295 EUGLYCAEMIC DIABETIC KETOACIDOSIS 8 0.0019
296 FALL 644 0.0019
297 BACTERIAL INFECTION 36 0.0019
298 DEHYDRATION 257 0.0019
299 RETCHING 41 0.0019
300 PRE-EXISTING CONDITION IMPROVED 12 0.0019
301 BLOOD LACTIC ACID INCREASED 10 0.0019
302 THROAT CANCER 8 0.0019
303 ESCHERICHIA URINARY TRACT INFECTION 8 0.0019
304 EATING DISORDER 40 0.0019
305 ABSCESS LIMB 8 0.0019
306 ENTERITIS 12 0.0019
307 ERUCTATION 36 0.0019
308 MEMORY IMPAIRMENT 255 0.0019
309 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
310 MONOPLEGIA 8 0.0018
311 PROTHROMBIN TIME PROLONGED 11 0.0018
312 HEAD INJURY 58 0.0018
313 ABDOMINAL PAIN UPPER 377 0.0018
314 GASTROINTESTINAL HAEMORRHAGE 153 0.0018
315 LETHARGY 105 0.0018
316 THINKING ABNORMAL 34 0.0018
317 HAEMORRHAGIC ANAEMIA 8 0.0018
318 DIABETIC NEUROPATHY 9 0.0018
319 CORONAVIRUS INFECTION 12 0.0018
320 GINGIVAL SWELLING 8 0.0018
321 PHYSICAL DISABILITY 8 0.0018
322 ANKLE FRACTURE 28 0.0018
323 CELLULITIS 91 0.0018
324 HEPATIC ENZYME ABNORMAL 9 0.0018
325 WHEELCHAIR USER 8 0.0018
326 FAECES SOFT 13 0.0018
327 INFUSION SITE PAIN 23 0.0018
328 ANGIOPATHY 10 0.0018
329 PRODUCT ADMINISTRATION INTERRUPTED 14 0.0018
330 AMNESIA 116 0.0018
331 OEDEMA PERIPHERAL 217 0.0018
332 INFUSION SITE ERYTHEMA 15 0.0018
333 DRUG PRESCRIBING ERROR 34 0.0018
334 SEASONAL ALLERGY 25 0.0018
335 SLUGGISHNESS 18 0.0018
336 ULCER 28 0.0018
337 LOWER GASTROINTESTINAL HAEMORRHAGE 13 0.0018
338 ENDOCARDITIS 9 0.0018
339 AZOTAEMIA 7 0.0018
340 OESOPHAGITIS 19 0.0017
341 CHOLELITHIASIS 57 0.0017
342 CHROMATURIA 39 0.0017
343 MELAENA 38 0.0017
344 INTESTINAL OBSTRUCTION 65 0.0017
345 MALABSORPTION 9 0.0017
346 SHOCK HAEMORRHAGIC 14 0.0017
347 DECUBITUS ULCER 14 0.0017
348 TENDON PAIN 13 0.0017
349 ACUTE RESPIRATORY FAILURE 33 0.0017
350 HYPERSOMNIA 49 0.0017
351 CHOKING 33 0.0017
352 STATUS EPILEPTICUS 19 0.0017
353 PLEURAL EFFUSION 102 0.0017
354 BEDRIDDEN 22 0.0017
355 CARDIOGENIC SHOCK 24 0.0017
356 ANAL ABSCESS 9 0.0017
357 WRIST FRACTURE 20 0.0017
358 TYPE 1 DIABETES MELLITUS 10 0.0017
359 CARDIAC FAILURE ACUTE 11 0.0016
360 HYPOPHAGIA 42 0.0016
361 MAJOR DEPRESSION 12 0.0016
362 ANAEMIA 313 0.0016
363 HAEMORRHOIDAL HAEMORRHAGE 8 0.0016
364 ALCOHOLISM 7 0.0016
365 DRUG DOSE OMISSION 270 0.0016
366 PULMONARY HYPERTENSION 34 0.0016
367 INCREASED TENDENCY TO BRUISE 15 0.0016
368 CEREBRAL DISORDER 12 0.0016
369 ABDOMINAL PAIN LOWER 41 0.0016
370 HAEMATOCRIT DECREASED 32 0.0016
371 STENT PLACEMENT 13 0.0016
372 DYSPHAGIA 153 0.0016
373 PANCREATITIS 84 0.0016
374 PULMONARY ARTERIAL HYPERTENSION 23 0.0016
375 RHABDOMYOLYSIS 66 0.0016
376 MENTAL IMPAIRMENT 38 0.0016
377 CYTOMEGALOVIRUS INFECTION 26 0.0016
378 PROCTALGIA 10 0.0016
379 FOOD ALLERGY 12 0.0016
380 CEREBRAL ISCHAEMIA 8 0.0016
381 CONSTIPATION 339 0.0016
382 ATELECTASIS 15 0.0016
383 GASTROENTERITIS VIRAL 28 0.0015
384 METABOLIC DISORDER 9 0.0015
385 INTENTIONAL DOSE OMISSION 44 0.0015
386 THERAPEUTIC RESPONSE UNEXPECTED 69 0.0015
387 BACK DISORDER 25 0.0015
388 CEREBRAL HAEMORRHAGE 55 0.0015
389 RENAL TUBULAR NECROSIS 15 0.0015
390 GASTRITIS 40 0.0015
391 PERIPHERAL SWELLING 234 0.0015
392 SERUM FERRITIN INCREASED 8 0.0015
393 HYPERKALAEMIA 53 0.0015
394 APPETITE DISORDER 10 0.0015
395 HYPOTHYROIDISM 48 0.0015
396 ANAL FISTULA 8 0.0015
397 SPINAL FRACTURE 30 0.0015
398 URINE OUTPUT DECREASED 13 0.0015
399 PRODUCT RESIDUE PRESENT 8 0.0015
400 KIDNEY INFECTION 29 0.0015
401 PNEUMONIA 477 0.0015
402 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 8 0.0015
403 DISABILITY 29 0.0015
404 GASTROOESOPHAGEAL REFLUX DISEASE 118 0.0015
405 SPINAL OPERATION 18 0.0015
406 NEPHROLITHIASIS 67 0.0015
407 TEMPERATURE INTOLERANCE 15 0.0015
408 LACTIC ACIDOSIS 47 0.0014
409 OLIGURIA 9 0.0014
410 HYPOXIA 51 0.0014
411 ACIDOSIS 11 0.0014
412 AUTOIMMUNE HEPATITIS 10 0.0014
413 SHOCK 33 0.0014
414 WEIGHT FLUCTUATION 15 0.0014
415 ATRIOVENTRICULAR BLOCK 11 0.0014
416 BREATH SOUNDS ABNORMAL 7 0.0014
417 GASTROINTESTINAL DISORDER 127 0.0014
418 HYPOKALAEMIA 65 0.0014
419 ILLNESS 145 0.0014
420 SURGERY 82 0.0014
421 SUBDURAL HAEMATOMA 20 0.0014
422 ORTHOSTATIC HYPOTENSION 24 0.0014
423 PRODUCT DOSE OMISSION IN ERROR 39 0.0014
424 DIVERTICULITIS 38 0.0014
425 COGNITIVE DISORDER 64 0.0014
426 RENAL IMPAIRMENT 115 0.0014
427 LOWER LIMB FRACTURE 26 0.0014
428 CATARACT OPERATION 8 0.0013
429 TENDERNESS 14 0.0013
430 OFF LABEL USE 1176 0.0013
431 GASTRIC DISORDER 46 0.0013
432 HYPOGLYCAEMIA 65 0.0013
433 PULMONARY OEDEMA 60 0.0013
434 HAEMOLYTIC ANAEMIA 12 0.0013
435 EPISTAXIS 100 0.0013
436 FISTULA 15 0.0013
437 LOCALISED INFECTION 32 0.0013
438 ECONOMIC PROBLEM 20 0.0013
439 BLOOD COUNT ABNORMAL 20 0.0013
440 ANORECTAL DISCOMFORT 7 0.0013
441 INGUINAL HERNIA 8 0.0013
442 RESPIRATION ABNORMAL 9 0.0013
443 LIVER INJURY 32 0.0013
444 DROOLING 9 0.0013
445 CHOLESTASIS 25 0.0013
446 LYMPHOEDEMA 9 0.0013
447 PERICARDIAL EFFUSION 30 0.0013
448 DELIRIUM 45 0.0013
449 HYPOMAGNESAEMIA 18 0.0013
450 ORAL CANDIDIASIS 17 0.0013
451 FUNGAL INFECTION 43 0.0013
452 BACK INJURY 14 0.0013
453 VITAMIN D DECREASED 11 0.0013
454 PSEUDOMONAS INFECTION 11 0.0013
455 ANURIA 11 0.0013
456 GASTROINTESTINAL INFLAMMATION 10 0.0013
457 DYSARTHRIA 48 0.0013
458 DRUG-INDUCED LIVER INJURY 40 0.0013
459 CARDIAC FAILURE 102 0.0013
460 DIVERTICULUM 9 0.0013
461 COLITIS 48 0.0013
462 RESPIRATORY FAILURE 92 0.0013
463 SLEEP APNOEA SYNDROME 24 0.0013
464 GENERAL PHYSICAL HEALTH DETERIORATION 145 0.0013
465 OSTEOPENIA 19 0.0013
466 POST PROCEDURAL COMPLICATION 24 0.0012
467 BALANCE DISORDER 108 0.0012
468 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 60 0.0012
469 BLOOD DISORDER 10 0.0012
470 PRODUCT COMMUNICATION ISSUE 11 0.0012
471 ASTHENIA 468 0.0012
472 HAEMOGLOBIN ABNORMAL 8 0.0012
473 HAEMOGLOBIN DECREASED 127 0.0012
474 LOSS OF CONSCIOUSNESS 158 0.0012
475 POST PROCEDURAL INFECTION 10 0.0012
476 MOUTH HAEMORRHAGE 9 0.0012
477 RED BLOOD CELL COUNT DECREASED 35 0.0012
478 DEAFNESS 32 0.0012
479 COELIAC DISEASE 12 0.0012
480 SENSITIVE SKIN 9 0.0012
481 HEPATOTOXICITY 27 0.0012
482 FEELING DRUNK 9 0.0012
483 MUSCLE SPASMS 222 0.0012
484 SPINAL COMPRESSION FRACTURE 10 0.0012
485 ARTERIOSCLEROSIS CORONARY ARTERY 8 0.0012
486 ILEUS 15 0.0012
487 HAEMORRHAGE INTRACRANIAL 18 0.0012
488 ABDOMINAL DISCOMFORT 200 0.0012
489 BREAST MASS 8 0.0012
490 DISTURBANCE IN ATTENTION 64 0.0012
491 NERVOUS SYSTEM DISORDER 37 0.0012
492 TOXIC EPIDERMAL NECROLYSIS 18 0.0012
493 WEIGHT DECREASED 330 0.0012
494 TREMOR 196 0.0012
495 BLOOD IRON DECREASED 14 0.0012
496 CIRCULATORY COLLAPSE 20 0.0012
497 PROCEDURAL COMPLICATION 9 0.0012
498 DYSURIA 43 0.0012
499 BLOOD ALKALINE PHOSPHATASE INCREASED 29 0.0012
500 SPEECH DISORDER 61 0.0012
501 PLATELET COUNT DECREASED 124 0.0012
502 LEUKOCYTOSIS 21 0.0012
503 FOOT FRACTURE 22 0.0012
504 VIRAL INFECTION 38 0.0011
505 HEPATOCELLULAR INJURY 16 0.0011
506 METABOLIC ACIDOSIS 36 0.0011
507 SKIN ULCER 29 0.0011
508 KNEE OPERATION 11 0.0011
509 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 8 0.0011
510 MYOSITIS 10 0.0011
511 BRAIN OEDEMA 14 0.0011
512 GAIT INABILITY 37 0.0011
513 MUSCLE ATROPHY 14 0.0011
514 GASTRIC ULCER 21 0.0011
515 LIMB INJURY 30 0.0011
516 SKIN LACERATION 12 0.0011
517 MULTI-ORGAN FAILURE 19 0.0011
518 MALAISE 482 0.0011
519 MUSCULOSKELETAL CHEST PAIN 17 0.0011
520 HYPERGLYCAEMIA 40 0.0011
521 BRAIN INJURY 11 0.0011
522 UNEVALUABLE EVENT 83 0.0011
523 DYSSTASIA 32 0.0011
524 PANCYTOPENIA 61 0.0011
525 CHOLECYSTITIS 13 0.0011
526 DIZZINESS 544 0.0011
527 DYSPEPSIA 107 0.0011
528 INTERNATIONAL NORMALISED RATIO INCREASED 31 0.0011
529 HYPOTHERMIA 11 0.0011
530 PNEUMONIA ASPIRATION 27 0.0011
531 TOOTH ABSCESS 11 0.0011
532 URINARY INCONTINENCE 32 0.0011
533 NAUSEA 854 0.0011
534 RENAL INJURY 32 0.0011
535 BRADYPHRENIA 7 0.0011
536 KETOACIDOSIS 8 0.0011
537 NEOPLASM MALIGNANT 71 0.0011
538 DIABETES MELLITUS 81 0.0011
539 GLOMERULAR FILTRATION RATE DECREASED 13 0.0011
540 FRACTURE 20 0.0011
541 CARDIAC ARREST 87 0.0011
542 VOMITING 495 0.0011
543 DRUG INTERACTION 167 0.0011
544 MICTURITION URGENCY 12 0.0010
545 FATIGUE 815 0.0010
546 THROMBOCYTOPENIA 117 0.0010
547 FULL BLOOD COUNT DECREASED 21 0.0010
548 LEUKOPENIA 52 0.0010
549 SECRETION DISCHARGE 13 0.0010
550 CYSTITIS 33 0.0010
551 HAEMOLYSIS 8 0.0010
552 SINUS BRADYCARDIA 10 0.0010
553 PRESCRIBED OVERDOSE 20 0.0010
554 CONCUSSION 8 0.0010
555 DRUG LEVEL INCREASED 17 0.0010
556 AUTOIMMUNE DISORDER 10 0.0010
557 HAEMORRHAGIC STROKE 8 0.0010
558 HAEMORRHAGE 107 0.0010
559 FEELING ABNORMAL 245 0.0010
560 HALLUCINATION 77 0.0010
561 DRUG EFFECT INCOMPLETE 37 0.0010
562 HEPATIC FUNCTION ABNORMAL 38 0.0010
563 SKIN HAEMORRHAGE 15 0.0010
564 MENTAL DISORDER 44 0.0010
565 TYPE 2 DIABETES MELLITUS 34 0.0010
566 THIRST 18 0.0010
567 HUNGER 14 0.0010
568 SEIZURE 115 0.0010
569 APHASIA 30 0.0010
570 BLOOD PRESSURE DECREASED 66 0.0010
571 LYMPHOPENIA 14 0.0010
572 NOCTURIA 12 0.0010
573 IMMUNE SYSTEM DISORDER 13 0.0010
574 TOOTH INFECTION 13 0.0010
575 SUBARACHNOID HAEMORRHAGE 10 0.0010
576 BLOOD THYROID STIMULATING HORMONE INCREASED 9 0.0010
577 POLYURIA 8 0.0010
578 POOR QUALITY SLEEP 21 0.0010
579 DEVICE RELATED INFECTION 15 0.0010
580 HYPOTENSION 195 0.0010
581 MITRAL VALVE INCOMPETENCE 11 0.0010
582 CARDIAC FAILURE CONGESTIVE 78 0.0010
583 NEUROTOXICITY 17 0.0010
584 EOSINOPHILIA 17 0.0010
585 STAPHYLOCOCCAL INFECTION 32 0.0010
586 WEIGHT INCREASED 217 0.0010
587 CHOLECYSTECTOMY 11 0.0010
588 DECREASED APPETITE 223 0.0010
589 GASTROENTERITIS 14 0.0010
590 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 50 0.0010
591 TINNITUS 44 0.0010
592 GALLBLADDER DISORDER 17 0.0010
593 METASTASES TO LUNG 11 0.0010
594 SPINAL DISORDER 9 0.0009
595 HALLUCINATION, VISUAL 20 0.0009
596 PNEUMOTHORAX 15 0.0009
597 ARTHROPOD BITE 7 0.0009
598 HEPATIC ENZYME INCREASED 64 0.0009
599 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
600 ROAD TRAFFIC ACCIDENT 39 0.0009
601 DYSPNOEA EXERTIONAL 35 0.0009
602 URINARY RETENTION 31 0.0009
603 HAEMATOMA 24 0.0009
604 PRURITUS GENERALISED 20 0.0009
605 DEVICE OCCLUSION 13 0.0009
606 ACCIDENT 11 0.0009
607 PERITONITIS 19 0.0009
608 COLITIS ULCERATIVE 41 0.0009
609 HIP ARTHROPLASTY 14 0.0009
610 SOMNOLENCE 184 0.0009
611 ANHEDONIA 24 0.0009
612 BLOOD CALCIUM INCREASED 8 0.0009
613 DYSPHONIA 53 0.0009
614 RESPIRATORY DISTRESS 25 0.0009
615 BLOOD PRESSURE ABNORMAL 18 0.0009
616 DENTAL CARIES 10 0.0009
617 BLOOD CREATININE INCREASED 59 0.0009
618 EXPIRED PRODUCT ADMINISTERED 30 0.0009
619 PARAESTHESIA ORAL 13 0.0009
620 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
621 OSTEOPOROSIS 37 0.0009
622 SKIN DISORDER 30 0.0009
623 HAEMOPTYSIS 25 0.0009
624 HYPOKINESIA 13 0.0009
625 BLOOD GLUCOSE DECREASED 43 0.0009
626 DRUG RESISTANCE 23 0.0009
627 CARDIOMEGALY 11 0.0009
628 GOUT 16 0.0009
629 HEADACHE 559 0.0009
630 THROAT IRRITATION 40 0.0009
631 NEPHROPATHY TOXIC 10 0.0009
632 BODY TEMPERATURE INCREASED 18 0.0009
633 LUPUS-LIKE SYNDROME 8 0.0009
634 RESTLESS LEGS SYNDROME 16 0.0009
635 BACK PAIN 204 0.0009
636 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
637 SWELLING 82 0.0009
638 FEMUR FRACTURE 27 0.0009
639 INFECTION 126 0.0009
640 POOR VENOUS ACCESS 9 0.0009
641 RESPIRATORY DISORDER 26 0.0009
642 INSOMNIA 231 0.0009
643 PETECHIAE 9 0.0009
644 MUSCULAR WEAKNESS 98 0.0009
645 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
646 SINUS DISORDER 17 0.0009
647 NEPHROPATHY 8 0.0009
648 RENAL FAILURE ACUTE 36 0.0008
649 THERAPY NON-RESPONDER 38 0.0008
650 SPUTUM DISCOLOURED 8 0.0008
651 BLOOD URINE PRESENT 16 0.0008
652 OROPHARYNGEAL PAIN 78 0.0008
653 BODY HEIGHT DECREASED 9 0.0008
654 HYPERLIPIDAEMIA 10 0.0008
655 BLOOD UREA INCREASED 14 0.0008
656 ELECTROCARDIOGRAM QT PROLONGED 30 0.0008
657 CARDIAC DISORDER 78 0.0008
658 CONTUSION 80 0.0008
659 HYPERTHYROIDISM 12 0.0008
660 COVID-19 145 0.0008
661 ADRENAL INSUFFICIENCY 10 0.0008
662 DYSPNOEA 466 0.0008
663 PRESYNCOPE 20 0.0008
664 PHARYNGEAL SWELLING 8 0.0008
665 HAEMATURIA 28 0.0008
666 RASH ERYTHEMATOUS 39 0.0008
667 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 147 0.0008
668 PAIN IN JAW 23 0.0008
669 NO ADVERSE EVENT 147 0.0008
670 HYPERCALCAEMIA 10 0.0008
671 ABASIA 20 0.0008
672 INTESTINAL PERFORATION 9 0.0008
673 MUSCULOSKELETAL PAIN 42 0.0008
674 TUBULOINTERSTITIAL NEPHRITIS 15 0.0008
675 OVARIAN CYST 8 0.0008
676 BRONCHITIS 59 0.0008
677 IMPAIRED DRIVING ABILITY 9 0.0008
678 ACUTE RESPIRATORY DISTRESS SYNDROME 14 0.0008
679 HEAD DISCOMFORT 14 0.0008
680 FEELING COLD 22 0.0008
681 NECK PAIN 44 0.0008
682 CHEST PAIN 145 0.0008
683 ABNORMAL BEHAVIOUR 31 0.0008
684 DRUG ADMINISTRATION ERROR 24 0.0008
685 LABORATORY TEST ABNORMAL 23 0.0008
686 ASPARTATE AMINOTRANSFERASE INCREASED 41 0.0008
687 EAR PAIN 15 0.0008
688 ATRIAL FIBRILLATION 75 0.0008
689 POLLAKIURIA 32 0.0008
690 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 155 0.0008
691 COVID-19 PNEUMONIA 9 0.0008
692 KNEE ARTHROPLASTY 16 0.0008
693 THROMBOSIS 61 0.0008
694 BLOOD GLUCOSE ABNORMAL 14 0.0008
695 COUGH 212 0.0008
696 GAIT DISTURBANCE 144 0.0008
697 IMPAIRED WORK ABILITY 16 0.0007
698 LIVER FUNCTION TEST INCREASED 16 0.0007
699 PYREXIA 256 0.0007
700 PHARYNGITIS STREPTOCOCCAL 8 0.0007
701 PRODUCT TASTE ABNORMAL 10 0.0007
702 DRUG INTOLERANCE 71 0.0007
703 PULMONARY THROMBOSIS 8 0.0007
704 GINGIVAL BLEEDING 10 0.0007
705 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 52 0.0007
706 WOUND INFECTION 8 0.0007
707 BLOOD GLUCOSE FLUCTUATION 8 0.0007
708 EYE SWELLING 27 0.0007
709 LIVER FUNCTION TEST ABNORMAL 21 0.0007
710 CATARACT 43 0.0007
711 CEREBROVASCULAR ACCIDENT 122 0.0007
712 NASAL CONGESTION 42 0.0007
713 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
714 LUNG DISORDER 35 0.0007
715 PANCREATITIS ACUTE 16 0.0007
716 BLOOD CALCIUM DECREASED 8 0.0007
717 BODY TEMPERATURE DECREASED 7 0.0007
718 PRODUCT DOSE OMISSION ISSUE 209 0.0007
719 INFLUENZA 79 0.0007
720 CHILLS 83 0.0007
721 BASAL CELL CARCINOMA 11 0.0007
722 BLADDER DISORDER 7 0.0007
723 DISCOMFORT 43 0.0007
724 PRURITUS 270 0.0007
725 THROAT TIGHTNESS 19 0.0007
726 DERMATITIS CONTACT 8 0.0007
727 SCAB 8 0.0007
728 ROTATOR CUFF SYNDROME 9 0.0007
729 SKIN CANCER 15 0.0007
730 SKIN DISCOLOURATION 32 0.0007
731 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
732 CARDIO-RESPIRATORY ARREST 29 0.0007
733 PRODUCTIVE COUGH 33 0.0007
734 SCIATICA 11 0.0007
735 NODULE 9 0.0007
736 RESPIRATORY ARREST 19 0.0007
737 VERTIGO 42 0.0007
738 JOINT SWELLING 83 0.0007
739 PULMONARY CONGESTION 9 0.0007
740 HERPES ZOSTER 39 0.0007
741 OXYGEN SATURATION DECREASED 38 0.0007
742 TRANSAMINASES INCREASED 15 0.0007
743 SINUSITIS 69 0.0007
744 PULMONARY MASS 10 0.0007
745 IMMUNODEFICIENCY 10 0.0007
746 ORAL HERPES 13 0.0007
747 RHINORRHOEA 43 0.0007
748 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
749 TOOTHACHE 12 0.0007
750 MOBILITY DECREASED 47 0.0007
751 DRY MOUTH 53 0.0007
752 MYALGIA 111 0.0007
753 FACE OEDEMA 11 0.0007
754 TRANSIENT ISCHAEMIC ATTACK 22 0.0007
755 NIGHT SWEATS 21 0.0007
756 NERVOUSNESS 34 0.0007
757 ORAL DISCOMFORT 9 0.0006
758 AGRANULOCYTOSIS 12 0.0006
759 SWELLING FACE 42 0.0006
760 CYST 8 0.0006
761 DELUSION 10 0.0006
762 LUNG INFECTION 10 0.0006
763 PRODUCT ADMINISTRATION ERROR 13 0.0006
764 PAIN 395 0.0006
765 ANXIETY 183 0.0006
766 SCAR 11 0.0006
767 BLOOD TEST ABNORMAL 9 0.0006
768 AGITATION 47 0.0006
769 SINUS TACHYCARDIA 9 0.0006
770 LUNG NEOPLASM MALIGNANT 26 0.0006
771 IRRITABILITY 38 0.0006
772 ADVERSE EVENT 58 0.0006
773 INCREASED APPETITE 12 0.0006
774 METASTASES TO LIVER 11 0.0006
775 ORAL PAIN 14 0.0006
776 BRADYCARDIA 33 0.0006
777 BLOOD PRESSURE INCREASED 95 0.0006
778 ANGER 21 0.0006
779 MIGRAINE 59 0.0006
780 APATHY 9 0.0006
781 DISEASE PROGRESSION 73 0.0006
782 TREATMENT FAILURE 51 0.0006
783 DEPRESSION 140 0.0006
784 CHEST DISCOMFORT 63 0.0006
785 PRODUCT DOSE OMISSION 40 0.0006
786 SLEEP DISORDER 43 0.0006
787 CARDIOMYOPATHY 9 0.0006
788 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
789 HEART RATE INCREASED 60 0.0006
790 BLISTER 34 0.0006
791 EAR INFECTION 16 0.0006
792 WHITE BLOOD CELL COUNT INCREASED 23 0.0006
793 INTENTIONAL SELF-INJURY 12 0.0006
794 TASTE DISORDER 12 0.0006
795 MIDDLE INSOMNIA 11 0.0006
796 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
797 AKATHISIA 8 0.0006
798 HEPATITIS 15 0.0006
799 BLOOD PRESSURE FLUCTUATION 14 0.0006
800 RASH GENERALISED 15 0.0006
801 PROTEINURIA 11 0.0006
802 CRYING 21 0.0006
803 ARTHRALGIA 240 0.0006
804 PAIN IN EXTREMITY 170 0.0006
805 WHEEZING 34 0.0006
806 APHONIA 8 0.0006
807 CARPAL TUNNEL SYNDROME 8 0.0006
808 DRUG INEFFECTIVE 752 0.0006
809 ALANINE AMINOTRANSFERASE INCREASED 35 0.0006
810 MOUTH ULCERATION 12 0.0006
811 HALLUCINATION, AUDITORY 9 0.0006
812 OBESITY 9 0.0006
813 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
814 DRUG ERUPTION 10 0.0006
815 AGEUSIA 14 0.0006
816 THERAPEUTIC PRODUCT EFFECT DECREASED 25 0.0006
817 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
818 MUSCLE TIGHTNESS 9 0.0006
819 BLOOD GLUCOSE INCREASED 104 0.0006
820 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
821 HYPERSENSITIVITY 102 0.0005
822 RESTLESSNESS 20 0.0005
823 STOMATITIS 33 0.0005
824 ABNORMAL DREAMS 15 0.0005
825 PSYCHOMOTOR HYPERACTIVITY 9 0.0005
826 SYNCOPE 54 0.0005
827 CONJUNCTIVITIS 10 0.0005
828 PALPITATIONS 63 0.0005
829 RESPIRATORY TRACT INFECTION 14 0.0005
830 NASOPHARYNGITIS 99 0.0005
831 COLON CANCER 8 0.0005
832 WOUND 15 0.0005
833 NEUROPATHY PERIPHERAL 51 0.0005
834 GLOSSODYNIA 12 0.0005
835 FEELING JITTERY 10 0.0005
836 DEEP VEIN THROMBOSIS 34 0.0005
837 INFLAMMATION 27 0.0005
838 TACHYCARDIA 46 0.0005
839 PNEUMONITIS 14 0.0005
840 RASH 224 0.0005
841 BURNING SENSATION 36 0.0005
842 THERAPY PARTIAL RESPONDER 8 0.0005
843 SWOLLEN TONGUE 16 0.0005
844 BONE PAIN 30 0.0005
845 DYSGEUSIA 38 0.0005
846 HYPOACUSIS 22 0.0005
847 ARTHRITIS 40 0.0005
848 NEUTROPENIA 69 0.0005
849 OSTEOMYELITIS 9 0.0005
850 LACRIMATION INCREASED 15 0.0005
851 PARAESTHESIA 78 0.0005
852 HYPERTENSION 105 0.0005
853 JOINT STIFFNESS 13 0.0005
854 NIGHTMARE 17 0.0005
855 BLINDNESS 20 0.0005
856 MULTIPLE FRACTURES 8 0.0005
857 MANIA 8 0.0005
858 LYMPHADENOPATHY 17 0.0005
859 INTENTIONAL PRODUCT MISUSE 42 0.0005
860 PHOTOPHOBIA 9 0.0005
861 DERMATITIS 10 0.0005
862 PERICARDITIS 8 0.0005
863 HYPOCALCAEMIA 9 0.0005
864 ACUTE MYOCARDIAL INFARCTION 14 0.0005
865 HEMIPARESIS 8 0.0005
866 WHITE BLOOD CELL COUNT DECREASED 51 0.0005
867 JOINT INJURY 10 0.0005
868 ANAPHYLACTIC SHOCK 12 0.0005
869 PARANOIA 8 0.0005
870 BLOOD PRESSURE SYSTOLIC INCREASED 9 0.0005
871 EYE PAIN 26 0.0005
872 URTICARIA 76 0.0005
873 FLUSHING 46 0.0005
874 ANAPHYLACTIC REACTION 25 0.0005
875 FIBROMYALGIA 11 0.0005
876 NEURALGIA 11 0.0005
877 HYPOAESTHESIA 67 0.0004
878 SNEEZING 10 0.0004
879 DYSKINESIA 18 0.0004
880 HEART RATE IRREGULAR 10 0.0004
881 BONE DISORDER 8 0.0004
882 ACCIDENTAL OVERDOSE 16 0.0004
883 MOVEMENT DISORDER 14 0.0004
884 ADVERSE DRUG REACTION 39 0.0004
885 ARTHROPATHY 24 0.0004
886 RASH MACULAR 15 0.0004
887 EYE DISORDER 14 0.0004
888 OSTEOARTHRITIS 18 0.0004
889 RASH PRURITIC 23 0.0004
890 LIMB DISCOMFORT 13 0.0004
891 MYOCARDIAL INFARCTION 73 0.0004
892 MYELOSUPPRESSION 15 0.0004
893 ERYTHEMA 85 0.0004
894 PRODUCT DISPENSING ERROR 9 0.0004
895 INFLUENZA LIKE ILLNESS 34 0.0004
896 VISUAL IMPAIRMENT 51 0.0004
897 MOOD SWINGS 13 0.0004
898 PALLOR 11 0.0004
899 SUICIDAL IDEATION 37 0.0004
900 VISION BLURRED 55 0.0004
901 HEART RATE DECREASED 14 0.0004
902 INJURY 28 0.0004
903 TOXICITY TO VARIOUS AGENTS 67 0.0004
904 DEPRESSED MOOD 21 0.0004
905 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
906 NEUTROPHIL COUNT DECREASED 16 0.0004
907 LIP SWELLING 13 0.0004
908 EMOTIONAL DISORDER 12 0.0004
909 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 9 0.0004
910 TOOTH LOSS 8 0.0004
911 ANGINA PECTORIS 11 0.0004
912 PANCREATIC CARCINOMA 11 0.0004
913 DRUG EFFECT DECREASED 20 0.0004
914 EXTRA DOSE ADMINISTERED 15 0.0004
915 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
916 MOOD ALTERED 10 0.0004
917 INCORRECT DOSE ADMINISTERED 83 0.0004
918 TOOTH DISORDER 8 0.0004
919 RASH MACULO-PAPULAR 8 0.0004
920 ARRHYTHMIA 17 0.0004
921 HYPERHIDROSIS 46 0.0004
922 PANIC ATTACK 13 0.0004
923 EMOTIONAL DISTRESS 43 0.0004
924 LOWER RESPIRATORY TRACT INFECTION 16 0.0004
925 BONE DENSITY DECREASED 11 0.0004
926 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
927 MUSCLE TWITCHING 8 0.0003
928 DIPLOPIA 9 0.0003
929 ASTHMA 39 0.0003
930 FEELING HOT 21 0.0003
931 UNDERDOSE 25 0.0003
932 MUSCULOSKELETAL STIFFNESS 30 0.0003
933 MEDICATION ERROR 19 0.0003
934 AGGRESSION 17 0.0003
935 PULMONARY EMBOLISM 32 0.0003
936 PAIN OF SKIN 9 0.0003
937 CORONARY ARTERY DISEASE 10 0.0003
938 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
939 DRY EYE 16 0.0003
940 OCULAR HYPERAEMIA 15 0.0003
941 PSORIASIS 41 0.0003
942 NEEDLE ISSUE 9 0.0003
943 SKIN EXFOLIATION 26 0.0003
944 ECZEMA 16 0.0003
945 MUCOSAL INFLAMMATION 8 0.0003
946 IMPAIRED HEALING 10 0.0003
947 DEVICE DISLOCATION 13 0.0003
948 PSORIATIC ARTHROPATHY 12 0.0003
949 EYE IRRITATION 17 0.0003
950 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 21 0.0003
951 EPILEPSY 9 0.0003
952 ANGIOEDEMA 13 0.0003
953 SKIN LESION 8 0.0003
954 BREAST CANCER 27 0.0003
955 PROCEDURAL PAIN 8 0.0003
956 FEBRILE NEUTROPENIA 19 0.0003
957 DERMATITIS ATOPIC 15 0.0003
958 INCORRECT DRUG ADMINISTRATION DURATION 8 0.0003
959 TARDIVE DYSKINESIA 8 0.0003
960 ALOPECIA 55 0.0003
961 PSYCHOTIC DISORDER 8 0.0003
962 INTERSTITIAL LUNG DISEASE 13 0.0003
963 EYE PRURITUS 9 0.0003
964 HOT FLUSH 20 0.0003
965 THERAPEUTIC RESPONSE DECREASED 16 0.0003
966 PRODUCT SUBSTITUTION ISSUE 13 0.0002
967 INJECTION SITE ERYTHEMA 28 0.0002
968 DRY SKIN 30 0.0002
969 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
970 COMPLETED SUICIDE 18 0.0002
971 WITHDRAWAL SYNDROME 9 0.0002
972 INJECTION SITE PAIN 57 0.0002
973 VAGINAL HAEMORRHAGE 8 0.0002
974 INJECTION SITE PRURITUS 12 0.0002
975 INJECTION SITE BRUISING 14 0.0002
976 CONVULSION 10 0.0002
977 DEVICE MALFUNCTION 12 0.0002
978 PRODUCT QUALITY ISSUE 23 0.0002
979 SKIN BURNING SENSATION 12 0.0002
980 DEVICE ISSUE 15 0.0002
981 MALIGNANT NEOPLASM PROGRESSION 17 0.0002
982 INJECTION SITE REACTION 11 0.0002
983 ACNE 12 0.0002
984 INFUSION RELATED REACTION 10 0.0002
985 OVERDOSE 32 0.0001
986 PRODUCT STORAGE ERROR 12 0.0001
987 MULTIPLE SCLEROSIS RELAPSE 9 0.0001
988 INJECTION SITE SWELLING 10 0.0001
989 RHEUMATOID ARTHRITIS 14 0.0001
990 INJECTION SITE HAEMORRHAGE 9 0.0001
991 FOETAL EXPOSURE DURING PREGNANCY 9 0.0001
992 DRUG ABUSE 8 0.0001
993 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001